Mei-Ling Chen
Impact in
- Oncology top 5%
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Pharmaceutical studies and practices 5
- Childhood Cancer Survivors' Quality of Life 2
-
- Drug Solubulity and Delivery Systems 3
- Co-authors
- Harald von Boehmer (1 shared paper)Richard Anthony Flavell (1 shared paper)Mikaël J. Pittet (1 shared paper)Ralph Weissleder (1 shared paper)Khashayarsha Khazaie (1 shared paper)Leonid Gorelik (1 shared paper)Nissim Hay (2 shared papers)Chia-Chen Chen (1 shared paper)
- Journals
- Journal of Pain and Symptom Management (3 papers)Journal of Clinical Microbiology (2 papers)RSC Advances (2 papers)Drug Metabolism and Disposition (2 papers)International Journal of Nursing Studies (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Mei-Ling Chen
34 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 124
- Oncology 744
- Immunology 502
- Aging 25
- Pharmaceutical Science 86
- Pharmacology 86
Countries citing papers authored by Mei-Ling Chen
This map shows the geographic impact of Mei-Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Ling Chen more than expected).
Fields of papers citing papers by Mei-Ling Chen
This network shows the impact of papers produced by Mei-Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Ling Chen. The network helps show where Mei-Ling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei-Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 674 | |
| 2 | 2008 | 673 | |
| 3 | 2017 | 207 | |
| 4 | 2008 | 120 | |
| 5 | 2018 | 98 | |
| 6 | 2004 | 94 | |
| 7 | 2006 | 75 | |
| 8 | 2011 | 73 | |
| 9 | 2000 | 65 | |
| 10 | 2007 | 64 | |
| 11 | 2009 | 56 | |
| 12 | 2009 | 54 | |
| 13 | 2019 | 45 | |
| 14 | 2014 | 40 | |
| 15 | 2014 | 40 | |
| 16 | 2013 | 38 | |
| 17 | 2000 | 37 | |
| 18 | 2005 | 36 | |
| 19 | 2001 | 31 | |
| 20 | 2012 | 30 |
About Mei-Ling Chen
Mei-Ling Chen is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science, Oncology, Immunology and Pharmacology, having authored 36 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer survivorship and care (6 papers), Pharmaceutical studies and practices (5 papers), Drug Solubulity and Delivery Systems (3 papers), Semiconductor Lasers and Optical Devices (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Organic Chemistry Synthesis Methods (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). The work is most often cited by research in Oncology (744 citations), Immunology (502 citations), Aging (25 citations), Pharmaceutical Science (86 citations) and Pharmacology (86 citations). Mei-Ling Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Harald von Boehmer, Richard Anthony Flavell, Mikaël J. Pittet, Ralph Weissleder, Khashayarsha Khazaie, Leonid Gorelik, Nissim Hay, Chia-Chen Chen, Youngkyu Park and Véronique Nogueira. Their work appears in journals such as Journal of Pain and Symptom Management, Journal of Clinical Microbiology, RSC Advances, Drug Metabolism and Disposition and International Journal of Nursing Studies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.